These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 31097291)

  • 1. HPV status in women with high-grade dysplasia on cervical biopsy and preceding negative HPV tests.
    Ge Y; Mody RR; Olsen RJ; Zhou H; Luna E; Armylagos D; Puntachart N; Hendrickson H; Schwartz MR; Mody DR
    J Am Soc Cytopathol; 2019; 8(3):149-156. PubMed ID: 31097291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade squamous intraepithelial lesion cervicovaginal paps with negative high-risk HPV testing, a prospective study with histological follow-up.
    Agoff SN; Brockmeyer AD; Barrie AM; Larson J
    Diagn Cytopathol; 2023 Aug; 51(8):475-479. PubMed ID: 37086174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-grade squamous intraepithelial lesion on Papanicolaou test: follow-up rates and stratification of risk for high-grade squamous intraepithelial lesion.
    Rufail M; Lew M; Pang J; Jing X; Heider A; Cantley RL
    J Am Soc Cytopathol; 2020; 9(4):258-265. PubMed ID: 32402830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV-ISH-Negative Invasive Cervical Squamous Cell Carcinoma: Histologic and Pap Test Results.
    Alexander C; White M; Maleki Z; Rodriguez EF
    Acta Cytol; 2019; 63(5):417-423. PubMed ID: 31195388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the diagnostic value of cervical cytology and HPV HR DNA testing for the diagnosis of low-grade and high-grade squamous intraepithelial lesions across different age groups.
    Paluszkiewicz A; Pruski D; Iwaniec K; Kędzia W
    Ginekol Pol; 2017; 88(3):141-146. PubMed ID: 28397203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High grade squamous intraepithelial lesion on high-risk HPV negative patients: Why we still need the Pap test.
    Sun H; Masand RP; Patel SJ; Padmanabhan V
    Diagn Cytopathol; 2018 Nov; 46(11):908-913. PubMed ID: 30488672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possibly carcinogenic HPV subtypes are a cause of HSIL and negative clinical HPV tests - A European prospective single center study.
    Reich O; Regauer S; Kashofer K
    Gynecol Oncol; 2020 Jul; 158(1):112-116. PubMed ID: 32354471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
    Ding Z; Li Y; Chen A; Song M; Zhang Y
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():32-36. PubMed ID: 27816739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histomorphologic assessment and distribution of high-risk human papillomavirus (HPV) types in cervical high-grade squamous intraepithelial lesions with unusual histomorphologic features.
    Gutnik H; Kastelic P; Oštrbenk Valenčak A; Poljak M; Strojan Fležar M
    Virchows Arch; 2020 Feb; 476(2):251-260. PubMed ID: 31754816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reporting rates of atypical glandular cells and their HPV testing and histologic follow-up results: a comparison between ThinPrep and SurePath preparations from a single academic institution.
    Liu S; Gibbons-Fideler IS; Tonkovich D; Shen R; Li Z
    J Am Soc Cytopathol; 2019; 8(3):128-132. PubMed ID: 31097288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Associated Factors of Abnormal Cervical Cytology and HighRisk HPV DNA among Bangkok Metropolitan Women.
    Tangjitgamol S; Kantathavorn N; Kittisiam T; Chaowawanit W; Phoolcharoen N; Manusirivithaya S; Khunnarong J; Srijaipracharoen S; Saeloo S; Krongthong W; Supawattanabodee B; Thavaramara T; Pataradool K
    Asian Pac J Cancer Prev; 2016; 17(7):3147-53. PubMed ID: 27509943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate biopsy of cervical cytology-negative and non-HPV-16/18 oncogenic types positive patients.
    Karaca İ; Öztürk M; Comba C; Demirayak G; Alay İ; Erdoğan VŞ; Hoşgören M; Yaşar L
    Diagn Cytopathol; 2018 Apr; 46(4):326-330. PubMed ID: 29460502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
    Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
    Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ideal strategy for cervical cancer screening in Japan: Result from the Fukui Cervical Cancer Screening Study.
    Kurokawa T; Onuma T; Shinagawa A; Chino Y; Kobayashi M; Yoshida Y
    Cytopathology; 2018 Aug; 29(4):361-367. PubMed ID: 29768678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
    Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP
    J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
    Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
    PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions.
    Cuzick J; Thomas Cox J; Zhang G; Einstein MH; Stoler M; Trupin S; Behrens CM
    Int J Cancer; 2013 Feb; 132(4):959-66. PubMed ID: 22806936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV-based screening for cervical cancer among women 55-59 years of age.
    Bergengren L; Lillsunde-Larsson G; Helenius G; Karlsson MG
    PLoS One; 2019; 14(6):e0217108. PubMed ID: 31199811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hrHPV positivity in ASC-US Papanicolaou tests from women with treated HPV- and non-HPV-related gynecologic malignancies.
    Paintal A; Heagley D
    J Am Soc Cytopathol; 2016; 5(4):216-220. PubMed ID: 31042511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.